{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-22-000187","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2022-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.993528+00:00","generated_at":"2026-06-26T05:36:47.616165+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Globus Medical names Dan Scavilla as CEO replacing Demski; prelim Q1 sales $230.5M +1.4% YoY","bullets":["David Demski resigned as CEO effective April 21, 2022; not due to any disagreement; will assist transition through June 30.","Daniel T. Scavilla appointed President & CEO; previously EVP Chief Commercial Officer and President of Trauma.","Preliminary Q1 2022 sales approx. $230.5M, up 1.4% vs Q1 2021; full-year 2022 guidance reaffirmed: $1.025B sales, non-GAAP EPS $2.10.","Scavilla's base salary increased to $450K; target annual non-equity incentive to $900K; receives option for 60,000 shares vesting 4 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-22-000187","json":"https://secwatch.observer/filing/0001562762-22-000187.json","markdown":"https://secwatch.observer/filing/0001562762-22-000187.md","text":"https://secwatch.observer/filing/0001562762-22-000187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/0001562762-22-000187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/gmed-20220421x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:36:47.616165+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9452fd1196","claim":"David M. Demski resigned as President and Chief Executive Officer at GLOBUS MEDICAL INC.","evidence_excerpt":"On April 20, 2022, Mr. Demski also notified the Board of his resignation as President and Chief Executive Officer of the Company, effective April 21, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/0001562762-22-000187-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a568b07d56","claim":"Daniel T. Scavilla was appointed as President and Chief Executive Officer at GLOBUS MEDICAL INC.","evidence_excerpt":"On April 21, 2022, the Board of Directors of the Company approved the appointment of Daniel T. Scavilla as President and Chief Executive Officer, effective April 21, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/0001562762-22-000187-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ab7ffbb6b3","claim":"Daniel T. Scavilla was appointed as Director at GLOBUS MEDICAL INC.","evidence_excerpt":"On April 21, 2022, the Board appointed Mr. Scavilla to serve as a member of the Board and as a member of the Nominating and Corporate Governance Committee with a term expiring at the Company’s annual meeting in 2023 to fill the vacancy created by the resignation of Mr. Demski.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/0001562762-22-000187-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c01355a580","claim":"David M. Demski resigned as Director at GLOBUS MEDICAL INC.","evidence_excerpt":"On April 20, 2022, David M. Demski notified the Chairman of the Board of Directors (the “Board”) of the Company of his resignation from the Board effective April 20, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276222000187/0001562762-22-000187-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}